IL4 and Alzheimer disease: During the initial or acute phase of AD, a type 2 (including innate lymphoid cells [ILCs] and T helper type 2 cells [Th2]) immune response characterized by interleukin (IL)-4, IL-13, and IL-5 predominates (Figure 1) (79–81).